InvestorsHub Logo
icon url

YJ4LIFE

04/03/13 3:02 PM

#50222 RE: rjanderson383 #50221

An update of what is going on would be nice. In the mean time, I just wait. Patience is all I'm saying. GAME is still on with all the MMs. They love to play with FIRE and they will get burn.
icon url

Dr Speculator Ninja

04/03/13 3:02 PM

#50223 RE: rjanderson383 #50221

LOL - no. Just people wanting in cheap, taking out stop-loss orders before a run up. News, patents...... if I had anymore powder I'd be buying as much as possible. I used the last of mine at .07 - which is STILL a fantastic purchase.

Watch the pop back up...
icon url

richme

04/03/13 3:07 PM

#50224 RE: rjanderson383 #50221

Yes, there are problems with management; cannot stick execute a plan to make things happen. There have been many problems with Elite that have been brush aside in deference to JT the illustrious. Start with two facilities for the work of one, lack of API, millions of shares issued, not meeting launch schedules; this does not bode well for a company that has nearly 470M shares issues and encumbered to preferred shares, countless others to compensate management for doing a poor job or none at all. If management pay was based on positive results they would be seriously overpaid. ELTP 0.064 -0.006 -8.57 2,001,045 0.0645 0.065 (that is our value). Sorry for those that rushed to buy at the last recommendation in $.09X; definitely should have waited but that was not in the recommendation. Only two called todays miserable performance.
icon url

Couch

04/03/13 3:16 PM

#50228 RE: rjanderson383 #50221

Seems you might want to read the sticky note from above where I publicly mention that I discussed matters with Dianne from IR. Nothing has changed since then. And I suggest a call to IR for anyone who has concerns. Seems the shorts are trying to shake the tree. Don't worry I just continue to load the boat. :-)

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=86236632

Investor Relations:
Dianne Will
(201) 367-7889
E Mail: dianne@elitepharma.com